Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Pfizer is cutting costs, growing its core business, and trading at a deep discount despite looming patent losses and COVID ...

Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) have gained a positive opinion from the European Medicines Agency’s Committee ...

Pfizer saw a staggering increase in call options trading, with investors snapping up 539,824 contracts, marking a 286% jump ...

While you can't see Buffett's other seven high-yielding dividend stocks in Berkshire's filings, the company, in essence, has ...

Tariffs, and their potential detrimental impacts on vehicle affordability, company profits, global competitiveness, and ...

Sixteen “safer” Ideal GASV emerged as buys for July. Top-ten tickers to buy were: CALM; FSK; MPLX; ET; YRD; ING; MO; VZ; NWBI ...

New capital, maturing pipelines, and a more global R&D mindset are pushing valuations higher, even as competition tightens.

New York drugmaker Pfizer and Mainz, Germany, immunotherapy company BioNTech said the European Commission, which generally follows CHMP's advice, will now review the recommendation, with a final ...

A majority of Americans have experienced the frustration of getting a healthcare insurance denial, often times finding no ...

Friday marked another winning day for the S&P 500 and Nasdaq, as both indexes posted fresh all-time intraday and closing ...

J.W. Cole Advisors Inc. significantly reduced its holdings in Amgen Inc., selling 4,695 shares, which resulted in a 28.9% ...